Albireo Pharma
(NASDAQ) ALBO
Albireo Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$57.39M
Net Income (TTM)
$137.38M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ALBO News
Is This a MannKind Killer?
Low-Profile Stocks for High Returns
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Albireo Pharma
Industry
Biotechnology
Sector
Health CareEmployees
130
CEO
Ronald H. W. Cooper
Website
www.albireopharma.comHeadquarters
Boston, MA 02109, US
ALBO Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-3%
Net Income Margin
-4%
Return on Equity
-85%
Return on Capital
-48%
Return on Assets
-50%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$39.22M
Operating Income
$123.48M
EBITDA
$19.82M
Operating Cash Flow
$107.56M
Capital Expenditure
$465.00K
Free Cash Flow
$108.02M
Cash & ST Invst.
$248.11M
Total Debt
$10.00M
Albireo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$9.83M
+168.3%
Gross Profit
$9.22M
+185.2%
Gross Margin
93.78%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
130
N/A
Net Income
$38.41M
-167.3%
EBITDA
$35.15M
-154.7%
Quarterly Fundamentals
Net Cash
$222.48M
-12.0%
Accounts Receivable
$2.03M
+55.2%
Inventory
$3.15M
+1506.6%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-50.11%
N/A
Return on Invested Capital
-48.10%
N/A
Free Cash Flow
$29.67M
-7.2%
Operating Cash Flow
$29.63M
-7.8%